Vera Therapeutics
Price & Volume
Stats
See moreOpen | $34.04 |
Previous Close | $34.60 |
Day Range | $33.35-$34.35 |
52W Range | $21.64-$56.05 |
Market Cap | $2.4B |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$5.87 |
News
See moreYahoo Finance • 21 days ago
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Vera Therapeutics Wins FDA Accelerated Approval For TRUTAKNA In Primary IgA Nephropathy
Yahoo Finance • 2 months ago
Vera gains after FDA nod for kidney disease therapy
Yahoo Finance • 2 months ago
Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy
About
CEO | Dr. Marshall W. Fordyce M.D. |
Address | 2000 Sierra Point Parkway, Brisbane, CA, United States, 94005 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 361 |